Gene · 10257
Papers3,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ABCC4 impacts megakaryopoiesis and protects megakaryocytes against 6-mercaptopurine induced cytotoxicity. | Drug Resist Updat | 2024 | 37988981 | PubTator, text mining | PubMed |
| Multidrug resistance protein 5 affects cell proliferation, migration and gemcitabine sensitivity in pancreatic cancer MIA Paca‑2 and PANC‑1 cells. | Oncol Rep | 2024 | 37975256 | PubTator, text mining | PubMed |
| Toward improved predictions of pharmacokinetics of transported drugs in hepatic impairment: Insights from the extended clearance model. | CPT Pharmacometrics Syst Pharmacol | 2024 | 37833845 | PubTator, text mining | PubMed |
| Reduction in cardiolipin reduces expression of creatine transporter-1 and creatine transport in growing hCMEC/D3 human brain microvessel endothelial cells. | Front Drug Deliv | 2023 | 40084065 | PubTator, text mining | PubMed |
| Structural insights into human ABCC4-mediated transport of platelet agonist and antagonist. | Nat Cardiovasc Res | 2023 | 39195918 | PubTator, text mining | PubMed |
| Association between genetic variants of membrane transporters and the risk of high-grade hematologic adverse events in a cohort of Mexican children with B-cell acute lymphoblastic leukemia. | Front Oncol | 2023 | 38269022 | PubTator, text mining | PubMed |
| Pharmacogenomics of intravenous immunoglobulin response in Kawasaki disease. | Front Immunol | 2023 | 38259468 | PubTator, text mining | PubMed |
| Up-regulation of ABCG1 is associated with methotrexate resistance in acute lymphoblastic leukemia cells. | Front Pharmacol | 2023 | 38259297 | PubTator, text mining | PubMed |
| Intestinal Membrane Function in Inflammatory Bowel Disease. | Pharmaceutics | 2023 | 38258040 | PubTator, text mining | PubMed |
| Definition of the Neurotoxicity-Associated Metabolic Signature Triggered by Berberine and Other Respiratory Chain Inhibitors. | Antioxidants (Basel) | 2023 | 38247474 | PubTator, text mining | PubMed |
| Decoding signaling mechanisms: unraveling the targets of guanylate cyclase agonists in cardiovascular and digestive diseases. | Front Pharmacol | 2023 | 38186653 | PubTator, text mining | PubMed |
| Cranberry Proanthocyanidins Mitigate Reflux-Induced Transporter Dysregulation in an Esophageal Adenocarcinoma Model. | Pharmaceuticals (Basel) | 2023 | 38139823 | PubTator, text mining | PubMed |
| Understanding Hyperuricemia: Pathogenesis, Potential Therapeutic Role of Bioactive Peptides, and Assessing Bioactive Peptide Advantages and Challenges. | Foods | 2023 | 38137270 | PubTator, text mining | PubMed |
| Assessment of the Performances of the Protein Modeling Techniques Participating in CASP15 Using a Structure-Based Functional Site Prediction Approach: ResiRole. | Bioengineering (Basel) | 2023 | 38135968 | PubTator, text mining | PubMed |
| Characterization of an iPSC-based barrier model for blood-brain barrier investigations using the SBAD0201 stem cell line. | Fluids Barriers CNS | 2023 | 38115090 | PubTator, text mining | PubMed |
| TCM and related active compounds in the treatment of gout: the regulation of signaling pathway and urate transporter. | Front Pharmacol | 2023 | 38094893 | PubTator, text mining | PubMed |
| Characteristics of ABCC4 and ABCG2 High Expression Subpopulations in CRC-A New Opportunity to Predict Therapy Response. | Cancers (Basel) | 2023 | 38067326 | PubTator, text mining | PubMed |
| Cytotoxicity and reversal effect of sertraline, fluoxetine, and citalopram on MRP1- and MRP7-mediated MDR. | Front Pharmacol | 2023 | 38026953 | PubTator, text mining | PubMed |
| Metallic elements combine with herbal compounds upload in microneedles to promote wound healing: a review. | Front Bioeng Biotechnol | 2023 | 38026844 | PubTator, text mining | PubMed |
| Albumin-bound kynurenic acid is an appropriate endogenous biomarker for assessment of the renal tubular OATs-MRP4 channel. | J Pharm Anal | 2023 | 38024860 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10257/papers?page=9